Tandem Diabetes Care Group
Operating companyHQ: United States
Tandem Diabetes Care Group has been party to 18 Unified Patent Court cases, 9 times as claimant and 9 times as respondent. The most recent on record is UPC CoA 120/2025 at the Court of Appeal. Its most recent decision on the merits was in UPC CFI 454/2023 at the Paris Central Division on 18 December 2024: patent upheld as granted.
- 2025-02-17UPC CoA 120/2025Court of AppealSettledTandem Diabetes Care Europe B.V. v Roche Diabetes Care GmbH
- 2025-01-20UPC CFI 11/2025Paris CDCosts onlyRoche Diabetes Care GmbH v Tandem Diabetes Care, Inc.
- 2024-04-19CC 20972/2024Dusseldorf LD—Rubin Medical ApS v F. Hoffmann-La Roche AG
- 2024-02-29UPC CFI 88/2024Hamburg LDSettledRoche Diabetes Care GmbH v Tandem Diabetes Care, Inc.
- 2024-01-02UPC CFI 504/2023Dusseldorf LDSettledF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
- 2023-11-30UPC CFI 454/2023Paris CDPatent upheld as grantedTandem Diabetes Care, Inc. v Roche Diabetes Care GmbH
- 2023-11-30UPC CFI 455/2023Paris CDSettledTandem Diabetes Care, Inc. v Roche Diabetes Care GmbH
- —UPC APP 11294/2025Dusseldorf LDProcedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
- —UPC APP 23079/2025Dusseldorf LDProcedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
- —UPC APP 28226/2025Dusseldorf LDProcedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.